MYBL2 and cancer: These findings are compatible with the conception that the anti‐proliferative effects of B‐MYB loss in HPV‐positive cancer cells could be, at least partially, compensated by a reactive induction of A‐MYB and, furthermore, that a highly efficient growth inhibition requires repression of both B‐MYB and A‐MYB.